The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

RGNX FINANCIAL STATEMENTS

Regenxbio Inc — balance sheet, income statement and cash flow trends

RGNXRegenxbio Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-250 M0250 M500 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue174.5 M $Gross Profit94.6 M $ · 54%Operating Income-164.1 M $ · -94%Pre-tax Income-196.4 M $ · -113%Net Income to Owners-196.4 M $ · -113%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue174.5 M $+12.0%
Gross Profit94.6 M $-24.0%
Operating Income-164.1 M $—
EBITDA-139.1 M $—
Net Income to Owners-196.4 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets386.6 M
  • Equity71.8 M $19%
  • Current Liabilities82.6 M $21%
  • Long-term Liabilities232.2 M $60%

Key Figures

YoY change
Total Assets386.6 M $-33.5%
Total Liabilities314.9 M $-14.3%
Total Equity71.8 M $-66.4%
Cash & ST Investments105.5 M $-67.4%
Total Debt69 M $-11.3%
Net Debt32.5 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M0200 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-300 M-200 M-100 M0-322.9 M $Operating286.9 M $Investing-26.4 M $Financing-62.3 M $Net Change

Key Figures

YoY change
Operating Cash Flow-322.9 M $—
Capital Expenditures4.2 M $+50.0%
Free Cash Flow-327.1 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on RGNX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.